BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11690567)

  • 1. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
    Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
    Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of electrical cardioversion in patients with previous embolic events.
    Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
    Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
    Mehta D; Baruch L
    Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.
    Arnold AZ; Mick MJ; Mazurek RP; Loop FD; Trohman RG
    J Am Coll Cardiol; 1992 Mar; 19(4):851-5. PubMed ID: 1545081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of electrical cardioversion in patients with atrial fibrillation.
    Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
    Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioversion of atrial arrhythmias: audit of anticoagulation management.
    Mayet J; Wasan B; Sutton GC
    J R Coll Physicians Lond; 1997; 31(3):313-6. PubMed ID: 9192336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
    Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
    J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
    Berger M; Schweitzer P
    Am J Cardiol; 1998 Dec; 82(12):1545-7, A8. PubMed ID: 9874066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolism in chronic atrial flutter: is the risk underestimated?
    Lanzarotti CJ; Olshansky B
    J Am Coll Cardiol; 1997 Nov; 30(6):1506-11. PubMed ID: 9362409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thromboembolic events in patients with atrial flutter.
    Seidl K; Hauer B; Schwick NG; Zellner D; Zahn R; Senges J
    Am J Cardiol; 1998 Sep; 82(5):580-3. PubMed ID: 9732883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
    Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE
    Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of direct current cardioversions for atrial arrhythmia.
    Johnston SD; Trouton TG; Wilson C
    Ulster Med J; 1998 May; 67(1):19-24. PubMed ID: 9652194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic anticoagulation of atrial flutter prior to cardioversion: meeting the "burden of proof".
    Silverman DI; Manning WJ
    Am J Med; 2001 Oct; 111(6):493-4. PubMed ID: 11690577
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.
    Wall C; Jankowski T; Naruka V; Mota P
    PLoS One; 2019; 14(1):e0210170. PubMed ID: 30605492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.